Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Cyberonics Announces Conference Call to Discuss Fiscal Year 2011 Second Quarter Financial Results

November 3, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Nov. 3, 2010 /- Cyberonics, Inc. (Nasdaq: CYBX ) today announced that the company will report financial results for the second quarter ended October 29, 2010 of its fiscal year ending April 29, 2011 on Monday, November 22, 2010 at 8:00 AM ET.  The company will conduct a...

TOPICS:

Georgia Tech Hosts Sickle Cell Disease Symposium

November 3, 2010 8:34 am | by Georgia Tech Institute of Technology | News | Comments

Georgia Tech will host the Sickle Cell Disease Symposium bringing together researchers, policy experts and community advocates to discuss the latest research and strategies for future success in combating this complex and debilitating blood disorder.

TOPICS:

Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions

November 3, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Nov. 3, 2010 /- Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today announced a collaboration with Sony DADC Austria AG for the co-development and manufacture of plastic consumables...

TOPICS:
Advertisement

Karyopharm collects $20M in first funding round

November 3, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Stealthy pharmaceutical startup Karyopharm Therapeutics Inc., born out of the ashes of Epix Pharmaceuticals, has raised a $20 million Series A financing round from unnamed backers, officials said.

Aetna 3Q profit jumps 53 percent on lower costs

November 3, 2010 4:45 am | by The Associated Press | News | Comments

Health insurer Aetna Inc. said Wednesday its third-quarter net income jumped 53 percent on lower benefits and expenses.The Hartford, Conn. company said a series of cost management moves and lower use of health care services gave profit a boost during the quarter. The medical benefit ratio,...

IMAPS-UK - 'Making MEMS Work ? BIG Ideas For Small Devices' Technical Seminar

November 3, 2010 4:35 am | by I-Micronews | News | Comments

UK Microelectronics Packaging Society (IMAPS-UK) has released details of its forthcoming ?Making MEMS Work ? BIG Ideas For Small Devices? Technical Seminar & Industry Networking Event being held at The Institute of System Level Integration (iSLI) in Edinburgh on 02 December 2010.

Biogen to cut work force by 13 percent

November 3, 2010 4:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Biogen Idec Inc., the second largest biotechnology company in Massachusetts with approved blockbuster drugs to treat Multiple Sclerosis, has announced it will cut its work force by 13 percent, closing a site in San Diego and consolidating sites in Eastern Massachusetts into the large...

WellPoint's 3Q profit climbs 1 percent

November 3, 2010 3:45 am | by TOM MURPHY - AP Business Writer - Associated Press | News | Comments

WellPoint Inc.'s net income inched up 1 percent in the third quarter, as the insurer cut expenses and saw gains from a reduction in health care use and leftover claims that came in lower than expected.The Indianapolis insurer also raised its 2010 earnings forecast, following a third-quarter...

Advertisement

Cardiogenesis Receives Research Award From Federal Government

November 3, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 3, 2010 /- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today announced the receipt of a grant of approximately $244,500 from the Qualifying Therapeutic Discovery Project...

TOPICS:

IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITASâ„¢

November 3, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

WEBSTER, Texas, Nov. 3, 2010 /- IDEV Technologies, Incorporated (IDEV), an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance to market the SUPERA VERITAS...

TOPICS:

Cleveland Clinic Unveils Top 10 Medical Innovations for 2011

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CLEVELAND, Nov. 3, 2010 /- From pill-sized cameras to radioactive compounds that let doctors "see" inside a patient's brain, Cleveland Clinic's Top 10 Medical Innovations for 2011 showcases new techniques, therapies and approaches to treating a host of diseases. The list of breakthrough...

TOPICS:

DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant

November 3, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Nov. 3, 2010 /- The DNA Medicine Institute, a biomedical research organization whose mission is to advance patient care, alleviate human suffering, and treat disease through innovation, has received a $222,999 grant from the U.S. government under the Qualifying...

TOPICS:

Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters

November 2, 2010 11:33 pm | by Bio-Medicine.Org | News | Comments

PHILADELPHIA and LONDON, Nov. 3, 2010 /- Pharmaceutical companies in the Asia Pacific region are increasingly adapting their business models from the production of generic drugs towards more high-risk, high-return research and development, according to a new report released today by CMR...

TOPICS:

MEMSCAP: 8% net profit for the third quarter 2010

November 2, 2010 10:34 pm | by I-Micronews | News | Comments

45% revenue growth for the first 9 months of the year and continuing operations profitable over the same period.

Telik Awarded $1.2 Million in Grants for Qualifying Therapeutic Development Projects

November 2, 2010 7:34 pm | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Nov. 2, 2010 /- Telik, Inc. (Nasdaq: TELK ) a clinical stage drug development company focused on developing drugs to treat cancer, announced that it has been awarded grants totaling $1,222,396 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP)....

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading